[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100619067":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":13,"studyPopulation":17,"armGroups":13,"interventions":13,"overallOfficials":13,"centralContacts":18,"locations":24,"responsibleParty":45,"collaborators":13,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":49,"sex":54,"minAge":55,"maxAge":13,"enrollmentInfo":56,"targetDuration":13,"studyType":59,"phases":13,"briefSummary":60,"conditions":61,"keywords":63,"overallStatus":27,"whyStopped":13,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"University Hospital, Strasbourg, France","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"Death rate in patients with probable or proven invasive Mucorales infection","Death rate at day 15 in patients with probable or proven invasive Mucorales infection","Day 15 after infection",null,{"allocation":13,"interventionModel":13,"interventionModelDescription":13,"primaryPurpose":13,"observationalModel":15,"timePerspective":16,"maskingInfo":13},"CASE_ONLY","RETROSPECTIVE","Adult patients with a diagnosis of probable or proven invasive pulmonary infection with Mucorales according to the 2020 EORTC\u002FMSGERC criteria",[19],{"name":20,"role":21,"phone":22,"phoneExt":13,"email":23},"baptiste Hoellinger, MD","CONTACT","33 3 69 55 05 45","baptiste.hoellinger@chru-strasbourg.fr",[25],{"facility":26,"status":27,"city":28,"state":13,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Service des Maladies Infectieuses et Tropicales - CHU de Strasbourg - France","RECRUITING","Strasbourg","67091","France","FR",{"type":33,"coordinates":34},"Point",[35,36],7.74553,48.58392,{"lat":36,"lon":35},[39,41,43],{"name":40,"role":21,"phone":22,"phoneExt":13,"email":23},"Baptiste Hoellinger, MD",{"name":40,"role":42,"phone":13,"phoneExt":13,"email":13},"PRINCIPAL_INVESTIGATOR",{"name":44,"role":42,"phone":13,"phoneExt":13,"email":13},"Clément XU-VUILLARD, MD",{"type":46,"investigatorFullName":13,"investigatorTitle":13,"investigatorAffiliation":13,"oldNameTitle":13,"oldOrganization":13},"SPONSOR","100619067","chest-ct-scan-in-pulmonary-mucormycosis-prognostic-value-100619067",false,"NCT07339800","Chest CT Scan in Pulmonary Mucormycosis: Prognostic Value","RadioMucor","Inclusion Criteria:\n\n* Patients aged 18 years or older\n* Treated at Strasbourg University Hospital between January 1, 2009, and June 3, 2025\n* With a diagnosis of probable or proven invasive pulmonary infection with Mucorales according to the 2020 EORTC\u002FMSGERC criteria\n* Having undergone at least one CT scan including the thoracic region\n\nExclusion Criteria:\n\n* No CT scan including the thoracic region\n* No diagnosis of probable or proven invasive pulmonary infection with Mucorales (EORTC\u002FMSGERC 2020 criteria)","ALL","18 Years",{"count":57,"type":58},80,"ESTIMATED","OBSERVATIONAL","Invasive pulmonary fungal infections caused by Mucorales are rare but severe and rapidly progressive, affecting immunocompromised patients. The role of chest imaging in their diagnosis is well established in the 2020 EORTC\u002FMSGERC criteria, and its use is almost systematic. However, the progression of lung parenchymal involvement and any potential prognostic radiological patterns in the follow-up of these infections are less well understood. This research aims to identify imaging characteristics predictive of favorable or unfavorable outcomes in infected patients, in order to better tailor follow-up and therapeutic options.",[62],"Pulmonary Mucormycosis",[62,64],"Fungal infections","2026-01-05",{"date":67,"type":68},"2026-01-14","ACTUAL",{"date":70,"type":68},"2025-09-18",{"date":72,"type":58},"2026-09-19",{"name":5,"class":6},1]